Well that's very true, although some on this board might say that there have been too many blackouts before the sunshine moments over the years.  Anyway, here we are.

I do think that 2020 will be a watershed year for RVX and that things will move to the upside.  I think we'll see some positive news on the FDA front (because why would the FDA even entertain discussions with this company if they didn't have something worth peddling?).  Further we'll almost certainly get some clarity on the financing end of things, and probably in a good way.

I've been in this thing for about 20 months now and waiting another year or two for things to gel is worth the wait considering the potential thing drug has.  As for communication, I thought that the last PR wasn't very well written and that makes me wonder how much stock we can put into each word that is communicated.  But in the big scheme of things its not a big deal.

Again, for the Canadians among us you may as well use the current low share and warrant prices to load up your TFSAs as much as possible and then we look for a bright and sunny 2020.  Although we may not completely shake the stigma of September 30 we will hopefully be able to put it well into the real view mirror in light of the positive developments that we are all hoping will materialize in the coming year.